Article Versions Notes

Geyer L, Wolf T, Chenard M-P, Cebula H, Schott R, Noel G, Guerin E, Pencreach E, Reita D, Entz-Werlé N, et al. p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances. Cancers. 2023; 15(5):1512. https://doi.org/10.3390/cancers15051512

Geyer, Lucas, Thibaut Wolf, Marie-Pierre Chenard, Helene Cebula, Roland Schott, Georges Noel, Eric Guerin, Erwan Pencreach, Damien Reita, Natacha Entz-Werlé, and et al. 2023. "p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances" Cancers 15, no. 5: 1512. https://doi.org/10.3390/cancers15051512

Geyer, L., Wolf, T., Chenard, M. -P., Cebula, H., Schott, R., Noel, G., Guerin, E., Pencreach, E., Reita, D., Entz-Werlé, N., & Lhermitte, B. (2023). p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances. Cancers, 15(5), 1512. https://doi.org/10.3390/cancers15051512